Rossari Biotech Limited

NSEI:ROSSARI Stok Raporu

Piyasa değeri: ₹44.2b

Rossari Biotech Yönetim

Yönetim kriter kontrolleri 4/4

Rossari Biotech's CEO is Sunil Chari, appointed in Jan 2003, has a tenure of 21.83 years. total yearly compensation is ₹12.13M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 30.87% of the company’s shares, worth ₹13.99B. The average tenure of the management team and the board of directors is 4.1 years and 5 years respectively.

Anahtar bilgiler

Sunil Chari

İcra Kurulu Başkanı

₹12.1m

Toplam tazminat

CEO maaş yüzdesi100.0%
CEO görev süresi21.8yrs
CEO sahipliği30.9%
Yönetim ortalama görev süresi4.1yrs
Yönetim Kurulu ortalama görev süresi5yrs

Son yönetim güncellemeleri

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Recent updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Jun 14
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

May 07
Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

CEO Tazminat Analizi

Sunil Chari'un ücretlendirmesi Rossari Biotech'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

₹1b

Jun 30 2024n/an/a

₹1b

Mar 31 2024₹12m₹12m

₹1b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹11m₹11m

₹1b

Dec 31 2022n/an/a

₹1b

Sep 30 2022n/an/a

₹995m

Jun 30 2022n/an/a

₹1b

Mar 31 2022₹10m₹10m

₹977m

Dec 31 2021n/an/a

₹957m

Sep 30 2021n/an/a

₹948m

Jun 30 2021n/an/a

₹892m

Mar 31 2021₹9m₹9m

₹802m

Dec 31 2020n/an/a

₹729m

Sep 30 2020n/an/a

₹695m

Jun 30 2020n/an/a

₹666m

Mar 31 2020₹8m₹7m

₹653m

Mar 31 2019₹5mn/a

₹457m

Mar 31 2018₹9mn/a

₹254m

Tazminat ve Piyasa: Sunil's total compensation ($USD144.26K) is below average for companies of similar size in the Indian market ($USD268.55K).

Tazminat ve Kazançlar: Sunil's compensation has been consistent with company performance over the past year.


CEO

Sunil Chari (59 yo)

21.8yrs

Görev süresi

₹12,130,000

Tazminat

Mr. Sunil Srinivasan Chari serves as a Managing Director of Rossari Biotech Limited since September 26, 2019 and serves as its Director since 2009. He is a co-founder of Rossari Biotech Limited in 2003. He...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Edward Menezes
Co-Founder & Executive Chairman15.8yrs₹12.13m31.13%
₹ 13.7b
Sunil Chari
Co-Founder21.8yrs₹12.13m30.87%
₹ 13.6b
Ketan Sablok
Chief Financial Officer1.5yrsVeri yokVeri yok
Mikhail Menezes
Director of Technicalno dataVeri yok0.24%
₹ 106.3m
Shifa Suresh
Vice President of Human Resources & Administration3.2yrsVeri yokVeri yok
Parul Gupta
Company Secretary & Compliance Officer5yrs₹1.00mVeri yok
Sunil Nair
Chief Human Resource Officer & Head Corporate Communicationsless than a yearVeri yokVeri yok
Yash Chari
Director of Marketing & Business Developmentno dataVeri yok0.30%
₹ 131.6m
Puneet Arora
Chief Executive Officer of Textile Chemicals Globalno dataVeri yokVeri yok
Prasad Gadkari
President of Manufacturingno dataVeri yokVeri yok

4.1yrs

Ortalama Görev Süresi

49yo

Ortalama Yaş

Deneyimli Yönetim: ROSSARI's management team is considered experienced (4.1 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Edward Menezes
Co-Founder & Executive Chairman15.8yrs₹12.13m31.13%
₹ 13.7b
Sunil Chari
Co-Founder15.8yrs₹12.13m30.87%
₹ 13.6b
Aseem Dhru
Independent Director5yrs₹2.87m0.00018%
₹ 79.5k
Annoottam Ghosh
Member of Advisory Boardno dataVeri yokVeri yok
Vikram Gupta
Member of Advisory Boardno dataVeri yokVeri yok
Goutam Bhattacharya
Independent Director5.9yrs₹2.77mVeri yok
Sharabh Pachory
Independent Director5yrs₹3.27mVeri yok
Jean Marcopoulos
Member of Advisory Boardno dataVeri yokVeri yok
Klaus Karl
Member of Advisory Boardno dataVeri yokVeri yok
Aparna Sharma
Non-Executive Independent Director1.5yrs₹2.93mVeri yok
Esha Achan
Additional Non-Executive Independent Director1.1yrs₹1.13mVeri yok
Gurudas Aras
Non- Executive Independent Directorless than a yearVeri yokVeri yok

5.0yrs

Ortalama Görev Süresi

64yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ROSSARI's board of directors are considered experienced (5 years average tenure).